TG Therapeutics Balance Sheet Analysis

Assets, liabilities, and stockholders equity in billions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for TG Therapeutics, Inc. (TGTX) - Annual data in billions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Current Assets
Cash and Cash Equivalents0.180.220.100.300.610.140.07
Short-Term Investments0.130.120.060.020.050.000.00
Cash & Short-Term Investments0.310.220.160.310.610.140.07
Accounts Receivable0.130.050.000.000.000.000.00
Inventory0.110.040.000.000.000.000.00
Other Current Assets0.020.010.000.000.000.010.00
Total Current Assets0.570.320.170.330.610.150.08
Non-Current Assets
Property, Plant & Equipment (Net)0.010.010.010.010.010.010.00
Long-Term Investments0.000.000.010.040.000.000.00
Goodwill0.000.000.000.000.000.000.00
Other Non-Current Assets0.000.000.000.000.010.000.00
Total Non-Current Assets0.010.010.030.050.020.010.00
Total Assets0.580.330.190.380.630.160.08
Current Liabilities
Accounts Payable0.000.040.040.050.040.030.04
Short-Term Debt0.000.000.000.000.020.000.00
Current Portion of Long-Term Debt0.000.000.000.000.020.000.00
Accrued Liabilities0.020.010.010.010.010.000.00
Deferred Revenue0.010.000.000.000.000.000.00
Other Current Liabilities0.080.000.000.000.020.050.00
Total Current Liabilities0.090.050.050.070.090.080.04
Non-Current Liabilities
Long-Term Debt0.250.110.070.070.020.040.00
Other Non-Current Liabilities0.000.000.000.000.000.000.02
Total Non-Current Liabilities0.260.120.080.080.020.040.02
Total Liabilities0.360.170.130.140.110.120.06
Stockholders' Equity
Common Stock0.000.000.000.000.000.000.00
Retained Earnings-1.53-1.55-1.53-1.33-0.98-0.70-0.53
Treasury Stock-0.010.000.000.000.000.000.00
Additional Paid-in Capital1.761.711.591.571.500.740.55
Shares Outstanding0.160.150.150.140.000.000.00
Total Stockholders' Equity0.220.160.060.240.520.040.02
Total Liabilities & Equity0.580.330.190.380.630.160.08